Lescarden Inc.

Lescarden Inc.
Stock Exchange Other OTC
EPS
$0
Market Cap
$419.91 K
Shares Outstanding
63.62 M
Public Float
-

Profile

Address
420 Lexington Avenue
New York New York 10170
United States
Employees -
Website http://www.catrix.com
Updated 07/08/2019
Lescarden, Inc. is a biotechnology company, which engages in the provision of development of natural, biologic therapies for the chronic wound care, dermatology and osteoarthritis markets. It focuses on research and development of biologic materials with focus on wound healing, clinical skin care, osteoarthritis and cancer applications. The company was founded by John Fletcher Prudden in 1960 and is headquartered in New York, NY.

Financials

View All

William E. Luther
President, CEO, CFO, CAO & Director
Xavier Gras Balaguer
Director